Renaissance Capital logo

EVA News

US IPO Weekly Recap: 4 IPOs offer dividends and drugs

BPMC

Yield IPOs yielded disappointing returns while biotech performance was anemic. 13 companies were added to the IPO calendar - including 7 in the health care sector - making this an inopportune week for a drop in the NASDAQ Composite. 49 companies have gone public in 2015, and average year-to-date...read more

Riverstone-backed Enviva Partners LP prices IPO at $20, the midpoint of the range

EVA

Enviva Partners LP, a Riverstone/Carlyle-backed supplier of utility-grade wood pellets, raised $200 million by offering 10 million shares at $20, the midpoint of the $19-$21 range. At its offer price, Enviva Partners LP commands a market cap of $476 million and an enterprise value of $594 million.  Enviva Partners will list on the NYSE under the symbol EVA. Barclays, Goldman...read more

Week ahead: 6 IPOs planned for the week of Apr 27

BSM

Up to six companies could price their IPOs this week. All are either LPs or health care companies (including three biotechs). Two LPs on deck, one offering power-generating wood pellets Enviva Partners LP (EVA) is backed by Riverstone/Carlyle and is the world’s largest...read more

Pellet seller to go public: Enviva Partners LP sets terms for $200 million IPO

EVA

Enviva Partners LP, the world's largest supplier of power generation wood pellets backed by Riverstone/Carlyle, announced terms for its IPO on Monday. The Bethesda, MD-based company plans to raise $200 million by offering 10 million units at a price range of $19 to $21. At the midpoint of the proposed range, Enviva Partners LP would command a market value of $476 million. ...read more